Anti-human CA153 protein recombinant antibody
A technology of antibody and binding protein, applied in the field of immunity, can solve the problems of low activity and poor affinity, and achieve the effect of high affinity and strong activity of binding protein
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0115] In this example, the restriction endonuclease and Prime Star DNA polymerase were purchased from Takara Company. MagExtractor-RNA extraction kit was purchased from TOYOBO Company. SMARTERTM RACE cDNA Amplification Kit was purchased from Takara Company. The pMD-18T vector was purchased from Takara Company. Plasmid extraction kit was purchased from Tiangen Company. Primer synthesis and gene sequencing were performed by Invitrogen.
[0116] 1.1. Primers
[0117] Amplify Heavy Chain and Light Chain 5'RACE Primers:
[0118] SMARTER II A Oligonucleotide:
[0119] 5'>AAGCAGTGGTATCAACGCAGAGGTACXXXXX<3';
[0120] 5'-RACE CDS Primer (5'-CDS): 5'>(T) 25 VN<3'(N=A,C,G,orT; V=A,G,orC);
[0121] Universal Primer A Mix(UPM):
[0122] 5’>CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT<3’
[0123] Nested Universal Primer A(NUP):
[0124] 5’>AAGCAGTGGTATCAACGCAGAGT<3’
[0125] mIg-kR: 5'>CCCGAATTCCTAACACTCATTCCTGTTGAAGCTCTTGAC<3'.
[0126] mIg-HR: 5'>TTTACCAGGAGAGTGGGAGAGGCTCTT...
Embodiment 2
[0143] Transient Transfection of Recombinant Antibody Expression Plasmids into CHO Cells and Identification of Antibody Activity in Expression Supernatant
[0144] The plasmid was diluted to 400ng / ml with ultrapure water, and the CHO cells were adjusted to 1.43×10 7 cells / ml in a centrifuge tube, mix 100ul plasmid with 700ul cells, transfer to electroporation cup, electroporation, transfer to 10ml CD CHO AGT medium, culture in 37 degree shaker (8% CO 2 , amplitude 150); sampling every day to detect cell viability, when the cell viability is lower than 50%, centrifugal cell culture supernatant, the antibody obtained (has sequence such as light chain and heavy chain shown in SEQ ID NO:11 and 12 ).
[0145] After analysis, the complementarity determining region (WT) of the heavy chain:
[0146] CDR-VH1 is G-A(X1)-T-F-T(X2)-N-Y-W
[0147] CDR-VH2 is E-I-R-V(X1)-K-S-N-Q(X2)-Y-A-S(X3)-H-Y-A-E-S-V;
[0148] CDR-VH3 is R-Q(X1)-I(X2)-T-T-L(X3)-Y-Y-A-M-D-Y;
[0149] Complementarity...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com